<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the susceptibility to natural killer (NK) or lymphokine activated killer (LAK) cell-mediated cytolysis of two pairs of drug sensitive/resistant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines which were extensively characterized at phenotypic and genotypic level </plain></SENT>
<SENT sid="1" pm="."><plain>In the DAUDI cell system, the acquired capability of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell variants to grow in the presence of a relatively high concentration of vinblastine (VBL) is associated with a marked increase to NK and LAK susceptibility </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast in the K-562 cell system, no correlation between drug-resistance, P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> expression and susceptibility to NK or LAK activity seems to occur </plain></SENT>
</text></document>